These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

954 related items for PubMed ID: 19640573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C, López Rodríguez D, Constenla Camba MI, Jimenéz Blanco A, Araujo LF, García-Medina J.
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [Abstract] [Full Text] [Related]

  • 3. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL, Bodner LJ, Ettinger LJ, Siegel RL, Gribbin C, Asch J, Drachtman RA.
    Cardiovasc Intervent Radiol; 2001 Jun; 24(6):395-9. PubMed ID: 11907746
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F, Forneris G, Borca M, Pozzato M.
    J Nephrol; 2006 Jun; 19(3):265-79. PubMed ID: 16874685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S.
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Venous thrombosis in relation to central venous catheters: pathogenesis, diagnosis, therapy, possibilities of prophylaxis].
    Hájek R, Matýsková M.
    Vnitr Lek; 1995 Jun; 41(6):415-20. PubMed ID: 7676664
    [Abstract] [Full Text] [Related]

  • 15. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A, Rasero L, Guerretta L, Perfetti E, Clerico M.
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer.
    Kefeli U, Dane F, Yumuk PF, Karamanoglu A, Iyikesici S, Basaran G, Turhal NS.
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):191-4. PubMed ID: 19267736
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
    Jansen FH, van der Straaten HM, Roest M, Haas F, de Groot PG, Fijnheer R.
    Haematologica; 2005 Apr; 90(4):499-504. PubMed ID: 15820946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.